DT
ADPT icon

Diversified Trust’s Adaptive Biotechnologies ADPT Stock Holding History

Diversified Trust’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
48,908
+3,132
+7% +$48K 0.02% 486
2026
Q1 		$635K Buy
45,776
+3,576
+8% +$57K 0.01% 608
2025
Q4 		$685K Buy
42,200
+2,224
+6% +$36.3K 0.01% 561
2025
Q3 		$598K Buy
39,976
+2,342
+6% +$28.5K 0.01% 577
2025
Q2 		$438K Buy
+37,634
New +$342K 0.01% 628

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Diversified Trust's ADPT Position: Q2 2026 in Review

Diversified Trust increased its Adaptive Biotechnologies (ADPT) stake by 6.8% in Q2 2026, buying an estimated $48K and bringing the position to 48,908 shares worth $1.05M. The position accounts for 0.02% of the portfolio, ranked #486.

Diversified Trust first reported a position in ADPT in Q2 2025 and has held it in 5 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Diversified Trust held 48,908 shares of Adaptive Biotechnologies worth $1.05M as of Q2 2026.
  • Diversified Trust bought 3,132 Adaptive Biotechnologies shares in Q2 2026, an estimated $48K.
  • Adaptive Biotechnologies made up 0.02% of Diversified Trust's portfolio in Q2 2026, its #486 holding.
  • Diversified Trust first reported a position in Adaptive Biotechnologies in Q2 2025 and has held it in 5 quarters since.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.